BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38622605)

  • 21. Effectiveness of prophylactic HPV vaccines against cervical abnormalities and HPV infection in Japan: The J-HERS 2021 multicenter study.
    Saeki Y; Saito M; Irie T; Itoh F; Enatsu A; Komura H; Fujii M; Fujii R; Hidaka N; Maehama T; Shirasu N; Waseda T; Shibata T; Takada E; Mibe K; Sakamoto J; Yamada S; Takakura M; Sasagawa T
    J Med Virol; 2024 Feb; 96(2):e29413. PubMed ID: 38314927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E6/E7 and E6
    Artaza-Irigaray C; Molina-Pineda A; Aguilar-Lemarroy A; Ortiz-Lazareno P; Limón-Toledo LP; Pereira-Suárez AL; Rojo-Contreras W; Jave-Suárez LF
    Front Immunol; 2019; 10():1676. PubMed ID: 31396215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guanylate-Binding Protein 1: An Emerging Target in Inflammation and Cancer.
    Honkala AT; Tailor D; Malhotra SV
    Front Immunol; 2019; 10():3139. PubMed ID: 32117203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
    Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer.
    Jin Y; Choi JW; Kim HJ; Eddouzi J; Kim SC; Ju W; Kim YH; Kim HJ
    Cancer Med; 2018 Nov; 7(11):5655-5664. PubMed ID: 30353680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papilloma virus early proteins E6 (HPV16/18-E6) and the cell cycle marker P16 (INK4a) are useful prognostic markers in uterine cervical carcinomas in Qassim Region--Saudi Arabia.
    Omran OM; AlSheeha M
    Pathol Oncol Res; 2015 Jan; 21(1):157-66. PubMed ID: 24925218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of an HLA-A24-restricted cytotoxic T lymphocyte epitope from human papillomavirus type-16 E6: the combined effects of bortezomib and interferon-gamma on the presentation of a cryptic epitope.
    Morishima S; Akatsuka Y; Nawa A; Kondo E; Kiyono T; Torikai H; Nakanishi T; Ito Y; Tsujimura K; Iwata K; Ito K; Kodera Y; Morishima Y; Kuzushima K; Takahashi T
    Int J Cancer; 2007 Feb; 120(3):594-604. PubMed ID: 17096336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
    Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
    Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between human papillomavirus 16, 18 DNA load and E6 protein expression in cervical intraepithelial neoplasia and cancer.
    Wu Z; Yu L; Lei X; Qin Y; Zhang X; Chen W; Qiao Y
    J Clin Virol; 2018 Nov; 108():6-11. PubMed ID: 30196013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-122 directly inhibits human papillomavirus E6 gene and enhances interferon signaling through blocking suppressor of cytokine signaling 1 in SiHa cells.
    He J; Ji Y; Li A; Zhang Q; Song W; Li Y; Huang H; Qian J; Zhai A; Yu X; Zhao J; Shang Q; Wei L; Zhang F
    PLoS One; 2014; 9(9):e108410. PubMed ID: 25265013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guanylate-Binding Protein-Dependent Noncanonical Inflammasome Activation Prevents Burkholderia thailandensis-Induced Multinucleated Giant Cell Formation.
    Dilucca M; Ramos S; Shkarina K; Santos JC; Broz P
    mBio; 2021 Aug; 12(4):e0205421. PubMed ID: 34399626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risks for cervical abnormalities in women with non-16/18 high-risk human papillomavirus infections in south Shanghai, China.
    Wang X; Wu S; Li Y
    J Med Virol; 2021 Nov; 93(11):6355-6361. PubMed ID: 34232523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guanylate-Binding Protein 1 Inhibits Nuclear Delivery of Kaposi's Sarcoma-Associated Herpesvirus Virions by Disrupting Formation of Actin Filament.
    Zou Z; Meng Z; Ma C; Liang D; Sun R; Lan K
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
    Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
    Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon-γ and IL-5 associated cell-mediated immune responses to HPV16 E2 and E6 distinguish between persistent oral HPV16 infections and noninfected mucosa.
    Paaso A; Koskimaa HM; Welters MJP; Kero K; Rautava J; Syrjänen K; van der Burg SH; Syrjänen S
    Clin Exp Dent Res; 2021 Oct; 7(5):903-913. PubMed ID: 33421352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and distribution of human papillomavirus (HPV) in Luoyang city of Henan province during 2015-2021 and the genetic variability of HPV16 and 52.
    Wang X; Han S; Li X; Wang X; Wang S; Ma L
    Virol J; 2022 Mar; 19(1):37. PubMed ID: 35246180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
    Brotherton JML; Tabrizi SN; Phillips S; Pyman J; Cornall AM; Lambie N; Anderson L; Cummings M; Payton D; Scurry JP; Newman M; Sharma R; Saville M; Garland SM
    Int J Cancer; 2017 Oct; 141(8):1576-1584. PubMed ID: 28677147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of HLA-DR1- and HLA-DR15-restricted human papillomavirus type 16 (HPV16) and HPV18 E6 epitopes recognized by CD4+ T cells from healthy young women.
    Gallagher KME; Man S
    J Gen Virol; 2007 May; 88(Pt 5):1470-1478. PubMed ID: 17412975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Therapeutic DNA Vaccine Targeting HPV16 E7 in Combination with Anti-PD-1/PD-L1 Enhanced Tumor Regression and Cytotoxic Immune Responses.
    Han X; Gao Z; Cheng Y; Wu S; Chen J; Zhang W
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.